FDA approval establishes setmelanotide as the first labeled option for acquired hypothalamic obesity, addressing a population ...

Researchers say discovery could establish the basis for a novel, tandem biomarker-peptide therapeutic approach to schizophrenia.

Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and ...

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms ...

EVERYDAY men are quietly shelling out $20,000 for penis-enhancing procedures that enlarge their manhood in less than an hour, ...

Current schizophrenia medications treat symptoms such as hallucinations and delusions, but do little for cognitive symptoms like disorganized thinking or executive dysfunction. As a result, many ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and ...

(magicmine/iStock/Getty Images Plus) The cannabis plant contains two powerful compounds that may reverse fatty liver disease ...

First and only FDA-approved therapy for the treatment of acquired hypothalamic obesity, a rare disease characterized by accelerated and sustained weight gain caused by hypothalamic injury or dysfuncti ...

Eli Lilly & Company (NYSE:LLY) is one of the best growth stocks to buy right now. On March 16, Eli Lilly announced positive ...

Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.